PharmaJet, Inc.
PharmaJet, Inc., headquartered in the United States, is a pioneering company in the biopharmaceutical industry, specialising in needle-free injection technology. Founded in 2009, PharmaJet has made significant strides in enhancing vaccine delivery systems, particularly in regions where traditional methods may pose challenges. The company’s core product, the PharmaJet Stratis® device, offers a unique, efficient, and pain-free method for administering vaccines, making it particularly valuable in global health initiatives. With a strong focus on innovation, PharmaJet has positioned itself as a leader in the market, contributing to improved vaccination rates and patient comfort. Notable achievements include partnerships with various health organisations, underscoring its commitment to advancing public health through cutting-edge technology.
DitchCarbon Score
How does PharmaJet, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PharmaJet, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PharmaJet, Inc.'s reported carbon emissions
PharmaJet, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, PharmaJet's climate commitments remain unclear, and there is no inherited emissions data from a parent or related organisation. Without specific emissions data or reduction initiatives, it is challenging to assess the company's environmental impact or sustainability efforts within the pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PharmaJet, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
